Changes in sleep architecture following chronic mild stress

Biological Psychiatry

Volumn 41, Issue 4, 1997, Pages 419-427

  Cheeta, Survjit ^a   Ruigt, Ge ^b   Van Proosdij, Jan ^b   Willner, Paul ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b NV ORGANON   (Netherlands)

Author keywords

Animal model of depression; Chronic mild stress; Rat; REM sleep; Sleep architecture

Indexed keywords

ANHEDONIA; ANIMAL MODEL; ARTICLE; CHRONICITY; DEPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SLEEP; STRESS;

EID: 18844470702     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00058-3     Document Type: Article

References (61)

1. American Psychiatric Association (1994): DSM IV Diagnostic and Statistical Manual of Psychiatric Disorders, 4th ed. Washington, DC.
2. Benca RM, Obermeyer WH, Thisted RA, Gillin C (1992): Sleep and Psychiatric Disorders: A meta-analysis. Arch Gen Psychiatr 49:651-668.
3. Berger M, Rieman D (1993): REM sleep in depression: An overview. J Sleep Res 2:211-223.
4. Berkowitz A, Sutton L, Janowsky D, Gillin JC (1990): Pilocarpine, an orally active muscarinic cholinergic agonist, induces REM sleep and reduces SWS in normal volunteers. Psychiatr Res 33:113-119.
5. Cartwright RD, Lloyd S, Paul L, Stephen son K (1980): Pressure to dream during major life crisis. Sleep Res 9:131.
6. Cartwright RD (1983): Rapid eye movement sleep characteristics during and after mood disturbing events. Arch Gen Psychiatr 40:197-201.
7. Cheeta S, Broekkamp C, Willner P (1994): Stereospecific reversal of stress-induced anhedonia by mianserin and its (+)-enantiomer. Psychopharmacology 116:523-528.
8. D'Aquila PS, Brain P, Willner P (1994a): Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression. Physiol Behav 56:861-867.
9. D'Aquila P, Borsini F, Willner P (1994b): Evaluation of the antidepressant potential of the novel 5-HT1a agonist BIMT-17, using the chronic mild stress procedure. Behav Pharmacol 5(Suppl 1):76.
10. Dement W (1960): The effect of dream deprivation. Science 131:1705-1707.
11. Fawcett J, Clark DC, Scheftner WA, Gibbons RD (1983): Assessing anhedonia in psychiatric patients: The pleasure scale. Arch Gen Psychiatr 40:79-84.
12. Ganguli R, Reynolds CF, Kupfer DJ (1987): Electroencephalagraphic sleep in young never-medicated schizophrenics: A comparison with delusional and non-delusional depressives and with healthy controls. Arch Gen Psychiatr 44:36-44.
13. Gillin JC, Mendelson WB, Sitaram N, Wyatt RJ (1978): The neuropharmacology of sleep and wakefulness. Ann Rev Pharmacol Toxicol 18:563-579.
14. Goodwin FK, Ebert MH, Bunney WE (1972): Mental effects of reserpine in man: A review. In Shader RI (ed.), Psychiatric Complications of Medical Drugs, pp 73-101. New York: Raven Press.
15. Henrikson SJ, Jacobs BC, Dement WC (1972): Dependence of REM sleep PGO spikes moves on cholinergic mechanisms. Brain Res 48:412-416.
16. Insel TR, Gillin JC, Moore A, Mendelson WB, Loewenstein RS, Murphy DC (1982): The sleep of obsessive-compulsive patients. Arch Gen Psychiatr 39:1372-1377.
17. Karczmar AG, Longo VG, de Carolis S ( 1970): A pharmacological model of paradoxical sleep: The role of cholinergic and monoamine systems. Physiol Behav 5:175-182.
18. Knowles JB, Cairns J, Mclean AW, Delva N, Prowse A, Waldron J, Letemendia FJ (1986): The sleep of remitted bipolar depressives: Comparison with sex and age-matched controls. Can J Psychiatr 31:295-298.
19. Konig JFR, Klippel RA (1963): The Rat Brain. A Sterotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. Baltimore, MD: Williams & Wilkins.
20. Kupfer DJ, Foster FG (1972): Intervals between onset of sleep and rapid-eye-movement sleep as an indicator of depression. Lancet 2:684-686.
21. Kupfer DJ (1976): REM latency: A psychobiological marker for primary depressive disease. Biol Psychiatr 11:159-174.
22. McNamara E, Reynolds CF, Soloff PH (1984): Electroencephalographic sleep evaluation of depression in borderline patients. Amer J Psychiatr 141:143-149.
23. Monleon S, D'Aquila P, Parra A, Simon VM, Brain PF, Willner P (1995): Attenuation of sucrose preference in mice by chronic mild stress and its restoration by imipramine. Psychopharmacology 117:453-457.
24. Monroe SM, Simons AD, Thase ME (1992): Social factors and the psychobiology of depression: Relations between life stress and rapid eye movement sleep latency. J Abnorm Psychology 101:528-537.
25. Moreau J-L, Jenck F, Martin JR, Mortas P, Haefely WE (1992): Antidepressant treatment prevents chronic mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behaviour in rats. Eur Neuropsychopharmacol 2:43-49.
26. Moreau J-L, Jenck F, Martin JR, Mortas P, Haefely WE (1993): Effects of moclobemide, a new generation reversible MAO-A inhibitor, in a novel animal model of depression. Pharmacopsychiatry 26:30-33.
27. Moreau J-L, Scherschlicht R, Jenck F, Martin JR (1995): Chronic mild stress-induced anhedonia model of depression: sleep abnormalities and curative effects of electroshock treatment. Behav Pharmacol 7:682-687.
28. Morris LR (1976): Fast Digital Signal Processing Software Package. DECUS Program Library, 11-296.
29. Muscat R, Sampson D, Willner P (1990): Dopaminergic mechanisms of imipramine action in an animal model of depression. Biol Psychiatr 28:223-230.
30. Muscat R, Papp M, Willner P (1992): Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotaline. Psychopharmacology 109:433-438.
31. Muscat R, Willner P (1992): Suppression of sucrose drinking by chronic mild unpredictable stress: A methodological analysis. Neurosci Biobehav Rev 16:507-517.
32. Oswald I, Thacore VR, Adam K, Brezinova V, Burack R (1975): Alpha-adrenergic receptor blockade increased human REM sleep. Br J Clin Pharmacol 2:107-110.
33. Papp M, Willner P, Muscat R (1991): An animal model of anhedonia: Attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology 104:255-259.
34. Papp M, Lappas S, Muscat R, Willner P (1992): Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress. J Psychopharmacol 6:352-356.
35. Papp M, Klimek V, Willner P (1994): Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine. Psychopharmacology 115:441-446.
36. Papp M, Moryl E, Willner P (1996): Pharmacological validation of the chronic mild stress model of depression. Eur J Pharmacol 296:129-136.
37. Reynolds CF, Kupfer DJ (1987): Sleep research in affective illness: State of the art circa 1987. Sleep 10:199-215.
38. Riemann D, Berger M (1989): EEG sleep in depression and in remission and the REM sleep response to the cholinergic agonist RS 86. Neuropsychopharmacology 2:145-152.
39. Ruigt GSF, van Proosdij J, van Delft AML (1989a): A large scale, high resolution, automated system for rat sleep staging. 1. Methodology and technical aspects. Electroencephalogr and Clin Neurophysiol 73:52-63.
40. Ruigt GSF, van Proosdij J, van Wezenbeek LACM (1989b): A large scale, high resolution, automated system for rat sleep staging. 11. Validation and application. Electroencephalogr and Clin Neurophysiol 73:64-71.
41. Rush AJ, Erman MK, Giles DE, Schlesser MA, Carpenter G, Vasavada N (1986): Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatr 43:878-884.
42. Sampson D, Muscat R, Willner P (1991): Reversal of antidepressant action by dopamine antagonists in an animal model of depression. Psychopharmacology 104:491-495.
43. Segal M, Olds J (1973): Activity of units in the hippocampal circuit of the rat during differential classical conditioning. J Comp Physiol Psychol 82:195-204.
44. Sitaram N, Dawson S, Wyatt RJ, Gillin JC (1976): REM sleep induction by physostigmine infusion during sleep. Science 191:1281-1283.
45. Sitaram N, Mendelson WB, Wyatt RJ, Gillin JC (1977): Time-dependent induction of REM sleep and arousal by physostigmine infusion during human sleep. Brain Res 122:562-567.
46. Sitaram N, Moore AM, Gillin JC (1978): Experimental acceleration and slowing of REM sleep ultradian rhythm of cholinergic agonist and antagonist. Nature 274:490-492.
47. Sitaram N, Nurnberger JI, Gershon ES, Gillin JC (1982): Cholinergic regulation of mood and REM sleep: A potential model and marker for vulnerability to depression. Am J Psychiatr 139:571-576.
48. Sluzewska A, Nowakowska E (1994): The effects of carbamazepine, lithium, and ketoconazole in chronic mild stress model of depression in rats. Behav Pharmacol 5(Suppl 1):86.
49. Spiker DG, Foster FG, Coble P, Love D, Kupfer DJ (1977): The sleep disorder in depressed alcoholics. Sleep Res 6:161.
50. Steiger A, von Bardeleben U, Herth T, Holsber F (1989): Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affect Dis 16:189-195.
51. Vogel GW, Thurmond S, Gibbons R, Sloan K, Walker M (1975): REM sleep reduction effects on depression syndromes. Arch Gen Psychiatry 32:765-777.
52. Vogel GW, Bogel F, McAbee RS, Thurmond AJ (1980): Improvement of depression by REM sleep deprivation. New findings and a theory. Arch Gen Psychiatry 37:247-253.
53. Vogel G, Vogel FA (1982): A new animal model of human endogenous depression. Sleep Res 11:222a.
54. Vogel G, Neill D, Hagler M, Kors D (1990): A new animal model of endogenous depression: A summary of present findings. Neurosci Biobehav Rev 14:85-91.
55. Walsbelen J, Robinson D, Lemmis C, Hackshaw R, Norman R, Alvir J (1990): Polysomnographic aspects of obsessive compulsive disorder. Sleep Res 19:177.
56. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987): Reduction of sucrose preference by chronic mild stress and its restoration by a tricyclic antidepressant. Psychopharmacology 93:358-364.
57. Willner P. (1991): Animal models as simulations of depression. Tips 12:131-136.
58. Willner P, Wilkes M, Orwin O (1991): Attributional style and perceived stress in endogenous and reactive depression. J Affect Dis 18:281-287.
59. Willner P, Muscat R, Papp M (1992): Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neurosci Biobehav Rev 16:525-534.
60. Willner P, Lappas S, Cheeta S, Muscat R (1994): Reversal of stress-induced anhedonia by the dopamine receptor agonist pramipexole. Psychopharmacology 115:454-462.
61. Winer BJ (1971): Statistical Principles in Experimental Design. London: McGraw Hill.